Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Seizures: early-phase trial registry
19 of 40 indexed Seizures trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #368 of 28,707 conditions by registered trial count.
40 US clinical trials · 19 currently recruiting · #368 of 28,707 conditions by registered trial count
Seizures: 40 US clinical trials tracked, 19 recruiting.
Seizures is the subject of 40 registered US clinical trials on ClinicalTrials.gov, 19 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 13 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Neurological Disorders and Stroke (NINDS), running 4 of these trials.
Enrollment posture brief
Registry condition seizures
OPEN 19 | RECR 48% | LATE 6 | EARLY 13 | RANK #368 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Metastatic Lung Non-Small Cell Carcinoma (48% recruiting · 40 trials)
Seizures lists 19 open slots (48% of 40 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Seizures on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Seizures is recruiting above its size-band peers.
19 of 40 indexed trials (47.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Seizures trials is spread across many organizations.
National Institute of Neurological Disorders and Stroke (NINDS) accounts for 4 of 40 trials (10%). 32 distinct sponsors appear on at least one study for this condition label.
-
Typical Seizures enrolment sits around 65 participants.
Median target enrolment is 65 among the 40 trials that report a genuine target (sentinel values excluded). 22 of those (55%) plan for fewer than 100 participants.
-
Seizures splits between interventional and observational designs.
27 interventional and 13 observational studies make up this index (67.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
40 total, page 1 of 1
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
University of New Mexi
NCT05140265
Pediatric Dose Optimization for Seizures in Emergency Medical Services
Stanford University
NCT05121324
Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children
Children's Hospital of Philadelphia
NCT03419260
Longitudinal Study of Neurogenetic Disorders
Columbia University
NCT03492060
Investigating Epilepsy: Screening and Evaluation
National Institute of Neurological Disorders and Stroke (NINDS)
NCT03478852
Genetic Markers of Cardiovascular Disease in Epilepsy
Mayo Clinic
NCT02824822
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
University of Florida
NCT02216500
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
SK Life Science
NCT05219617
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
Neuroelectrics Corporation
NCT04770337
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
Ayal A. Aizer, MD
NCT07130786
Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.
Epitel
NCT06027749
Oxygen Toxicity: Mechanisms in Humans
Duke University
NCT05761756
Pharmacological Modulation of Brain Oscillations in Memory Processing
University of Texas Southwestern Medical Center
NCT05594017
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
University of California, San Francisco
NCT06401707
Ear-Seizure Detection (EarSD) Study
Felicia Chu
NCT06598189
Modulating Movement Intention Via Cortical Stimulation
NYU Langone Health
NCT03233399
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
University of California, San Francisco
NCT05851391
Glioblastoma Remote Monitoring and Care - Research Protocol
Case Comprehensive Cancer Center
NCT06129760
Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients
Yale University
NCT05784805
Neural Circulatory Control and SUDEP Risk.
Mayo Clinic
NCT02813980
RNS System LGS Feasibility Study
NeuroPace
NCT05339126
BHV-7000 Responsive Neurostimulation System (RNS) Study
Yale University
NCT07125261
Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly.
US Department of Veterans Affairs
NCT00007670
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
Children's Hospital Medical Center, Cincinnati
NCT00088452
Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures
University of Utah
NCT00326612
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
GlaxoSmithKline
NCT00232596
Revisiting Survey Investigating Why Patients Are Not Receiving Home Anti-convulsant Medication Prior to Surgery/or Procedure Involving General Anesthesia
Vidya Raman
NCT01897974
Hypovitaminosis D in Neurocritical Patients
University of Utah
NCT02881957
Clobazam in Patients With Lennox-Gastaut Syndrome
Lundbeck
NCT00518713
Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study
Icahn School of Medicine at Mount Sinai
NCT00041951
Metabolic Abnormalities in Children With Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00001325
Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders
INSYS Therapeutics
NCT02324673
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
Roxane Laboratories
NCT01703468
Evaluation of StatNet Device for Electroencephalogram (EEG) Recordings
Beth Israel Deaconess Medical Center
NCT03103425
Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector
U.S. Army Office of the Surgeon General
NCT00534378
Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene
Children's Hospital Medical Center, Cincinnati
NCT03892798
Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00001666
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
National Institute of Neurological Disorders and Stroke (NINDS)
NCT02019667
Effect of Perampanel on Peritumoral Hyperexcitability in HGG
Dana-Farber Cancer Institute
NCT04497142
Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001912
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 7 |
| Phase 3 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Seizures records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Seizures trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Seizures page
40 registered trials, 19 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 19 Seizures trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Neurological Disorders and Stroke (NINDS) sponsors the most Seizures trials on record, review their full trial history before evaluating a specific study. See National Institute of Neurological Disorders and Stroke (NINDS)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Seizures condition card totals 40 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.